Santé et Bio technologies
Instituts Hospitalo-Universitaires
Institut Hospitalo-Universitaire Imagine
Imagine
Mots-clés : Genetic diseases; physiopathology; translational research; clinical research
Established in 2007 and awarded IHU status in 2011 under the French Investments for the Future Programme, Institut Imagine brings together research, care, education and innovation to accelerate solutions for patients with genetic diseases. Founded by AP-HP, Inserm and Université Paris Cité, with the support of the City of Paris, AFM-Téléthon and Fondation des Hôpitaux, it has developed a unique patient-centered “bedside-to-bench-and-back” model.
Since 2011, the Institute has built an interdisciplinary ecosystem linking clinicians, researchers and patients to address a major public health challenge: genetic diseases affect over 3 million people in France, while many patients still lack a diagnosis or targeted treatment. Imagine has delivered strong results in research, prevention and care, training, innovation, technology transfer, industrial partnerships, societal engagement and fundraising, while maintaining financial strength and high international attractiveness.
Its new 2025–2034 strategic roadmap aims to deepen the integration of science and care through omics, systems biology, artificial intelligence and experimental human biology, to transform genetic medicine and strengthen Imagine’s leadership in the field.
The year 2025 marked a major transition, with Professor Bana Jabri taking office as Director, alongside renewed governance bodies. Scientific development was reinforced through the recruitment of three junior professors and the award of an Excellence Chair in Biology. Research infrastructure was also strengthened: the bioinformatics platform evolved into a collaborative hub combining computational and biological expertise, and a new Research Equipment Department was created to support advanced technologies. Innovation progressed with a new Biolaunchpad entrepreneurship cohort, support for the startup REPLICO, and major clinical research initiatives including the DREPAMIR trial.
L'auteur de ce résumé est le coordinateur du projet, qui est responsable du contenu de ce résumé. L'ANR décline par conséquent toute responsabilité quant à son contenu.
Informations générales
Acronyme projet : Imagine
Référence projet : 10-IAHU-0001
Région du projet : Île-de-France
Discipline : 5 - Bio Med
Aide PIA : 91 943 137 €
Début projet : juin 2011
Fin projet : décembre 2028
Coordination du projet : Bana JABRI
Email : bana.jabri@institutimagine.org
Consortium du projet
Etablissement coordinateur : Fondation IMAGINE
Partenariat : AP-HP, INSERM Paris 13, Département de Paris, Association Française contre les Myopathies (Paris), Fondation Hôpitaux de France -Hôpitaux de Paris, Université Paris Cité